Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes.
Abdul-Ghani M, Maffei P, DeFronzo RA.
Lancet Diabetes Endocrinol. 2024 Sep;12(9):674-680. doi: 10.1016/S2213-8587(24)00127-X. Epub 2024 Aug 1.
Type 2 diabetes: etiology and reversibility.
Taylor R.
Diabetes Care. 2013 Apr;36(4):1047-55. doi: 10.2337/dc12-1805.
Insulin Resistance: From Mechanisms to Therapeutic Strategies.
Lee SH, Park SY, Choi CS.
Diabetes Metab J. 2022 Jan;46(1):15-37. doi: 10.4093/dmj.2021.0280. Epub 2021 Dec 30.
Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition.
Bielka W, Przezak A, Molęda P, Pius-Sadowska E, Machaliński B.
Cardiovasc Diabetol. 2024 Feb 10;23(1):62. doi: 10.1186/s12933-024-02145-x.
Pathogenesis of type 2 diabetes mellitus.
DeFronzo RA.
Med Clin North Am. 2004 Jul;88(4):787-835, ix. doi: 10.1016/j.mcna.2004.04.013.
Type 2 diabetes: a multifaceted disease.
Pearson ER.
Diabetologia. 2019 Jul;62(7):1107-1112. doi: 10.1007/s00125-019-4909-y. Epub 2019 Jun 3.
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review.
Sebastian SA, Padda I, Johal G.
Curr Probl Cardiol. 2024 Feb;49(2):102344. doi: 10.1016/j.cpcardiol.2023.102344. Epub 2023 Dec 14.
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N.
Diabetes Res Clin Pract. 2014 Aug;105(2):141-50. doi: 10.1016/j.diabres.2014.04.006. Epub 2014 Apr 13.
A comprehensive definition for metabolic syndrome.
Huang PL.
Dis Model Mech. 2009 May-Jun;2(5-6):231-7. doi: 10.1242/dmm.001180.
Adipocyte Regulation of Insulin Sensitivity and the Risk of Type 2 Diabetes.
Santoro A, Kahn BB.
N Engl J Med. 2023 Jun 1;388(22):2071-2085. doi: 10.1056/NEJMra2216691.
